2nd day Alinity I Analyzer maintenance service with required reagents

Key Dates
Due Date

-

Posted Date

-

Agency & Value
Agency

CDC OFFICE OF ACQUISITION SERVICES

Contract Value

Not provided

Codes & Classification
Solicitation Number

75D30126Q78791

NAICS

325413 - In-Vitro Diagnostic Substance Manufacturing

Classification Code

Q301

Additional Details
Set Aside

NONE

Place of Performance

Atlanta, Georgia, UNITED STATES

SourceSAM
Documents2
The Centers for Disease Control and Prevention (CDC), Office of Acquisition Services, has issued a combined synopsis/solicitation for the procurement of urgent maintenance and OEM support services for an Alinity I Analyzer, including the provision of required reagents. This procurement is being conducted under a sole source, firm-fixed-price purchase order with Abbott Laboratories, the original equipment manufacturer (OEM) and sole provider of the Alinity I Analyzer and its proprietary support infrastructure. The procurement is valued below the Simplified Acquisition Threshold (SAT) and is being processed in accordance with FAR Part 13 Simplified Acquisition Procedures, specifically under the authority of FAR 13.106-1(b)(1)(i). The primary objective of this procurement is to secure a comprehensive service agreement—specifically, the "Alinity I Always on 2nd Day" service plan—for the Alinity I Analyzer instrument utilized by the Division of Viral Hepatitis Laboratory Branch at the CDC. This instrument is critical for running FDA-cleared antigen and antibody assays for Hepatitis viruses, including the only available serological marker for active Hepatitis C virus (HCV) infection and prototype assays for Hepatitis D and E. The service agreement is intended to ensure uninterrupted operation and compliance with manufacturer specifications, thereby supporting the CDC’s mission in viral hepatitis research and diagnostics. The scope of the required services includes: - Full coverage of the Alinity I Analyzer instrument, encompassing all repairs, replacements, and labor associated with instrument failures. - Unlimited service visits during standard business hours (Monday through Friday, 8:00 a.m. to 5:00 p.m. local time, excluding holidays). - All repairs to include necessary parts, labor, and travel expenses. - Predictive maintenance services, as indicated by the AlinIQ charge. - Emergency repair response within 24 hours of request during business hours. - Field application support to ensure optimal instrument performance. - Ongoing technical support via email and phone throughout the life of the agreement, available during standard business hours. This requirement is classified under NAICS code 325413 (In-Vitro Diagnostic Substance Manufacturing), with no set-aside for small businesses. The place of performance is the CDC’s Roybal campus, located at 1600 Clifton Rd, Atlanta, GA 30329, specifically in Building 18, 3rd floor, Room 3-425. The CDC has determined that Abbott Laboratories is the only known source capable of providing the necessary proprietary reagents, diagnostics, and service infrastructure for the Alinity I Analyzer. While this is a sole source procurement, the government will consider all quotations or responses received within fifteen (15) days of the notice issuance for the purpose of determining whether to conduct a competitive procurement. Interested parties must reference RFQ number 75D30126Q78791 and submit responses by 12:00 PM EST on Monday, January 26, 2026. All correspondence should be directed to Gary Morgan, Contract Specialist, at [email protected], with secondary contact Liubov Kriel at [email protected]. This procurement is for supplies and license services essential to the CDC’s ongoing laboratory operations and public health mission. The contract will be awarded as a firm-fixed-price purchase order, and the terms and conditions are governed by the Federal Acquisition Circular 2021-07. The notice remains active and is posted on SAM.gov under Opportunity ID b546b5eb85534e7bb319fb8d5dc2fb2f. Contractors evaluating this opportunity should note the specialized nature of the requirement, the sole source justification, and the critical role of the Alinity I Analyzer in supporting the CDC’s Division of Viral Hepatitis. Only entities with direct access to Abbott’s proprietary technology and support infrastructure will be considered qualified for this procurement.